Latest Articles
Most elderly patients with subclinical hypothyroidism do not need to be treatedAge-adjusted thyrotropin reference ranges, consideration of individual circumstances, and a wait-and-see approach for mild subclinical hypothyroidism might be more suitable than a universal treatment strategy.
- Psychedelics in the medical toolbox?
Given the historical association of psychedelics as “recreational” mind-altering compounds within countercultures of the 1960s and 1970s, their current introduction into several aspects of medical practice is a surprise to many.
- Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period?
Clinical judgment should guide this decision, taking into account patient symptoms and the presence of factors that may delay gastric emptying and increase risk for aspiration.
- Subclinical hypothyroidism: What’s in a name?
Clinicians should remain thoughtful about the variability in aging biology and not be blinded by a name.
- Coronary artery bypass grafting: Practice trends and projections
Future directions include expanding the use of multiarterial grafting, offering patients less-invasive approaches, and enhancing operative recovery.
- Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
There is no cross-reactivity between antimicrobial and nonantimicrobial sulfonamides, and patients with a history of immunoglobulin E–mediated reaction to a sulfonamide antibiotic can receive nonantimicrobial sulfonamides.
- Cardiovascular disease in people living with HIV: Risk assessment and management
Because people living with HIV develop coronary artery disease much earlier than the general population, careful attention must be given to assessment and management of their cardiovascular risk.
